ITB-Iplus/GDF-MED/2025/1_Annex J. Global Drug Facility artwork development guidelines
ITB-Iplus/GDF-MED/2025/1_Annex I. GMSD address list
ITB-Iplus/GDF-MED/2025/1_Annex H. Indicative non-binding estimated quantities
ITB-Iplus/GDF-MED/2025/1_Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines
ITB-Iplus/GDF-MED/2025/1_Annex F. CDP Technical Tender Submission - Instructions for use
ITB-Iplus/GDF-MED/2025/1_Annex E. Declaration of supply restrictions to countries
ITB-Iplus/GDF-MED/2025/1_Annex D. i+solutions model Long-Term Agreement
ITB-Iplus/GDF-MED/2025/1 _Annex C. List of priority countries for TB medicines registration updated
ITB-Iplus/GDF-MED/2025/1 _Annex B - List and technical specifications of products requested
ITB-Iplus/GDF-MED/2025/1_Annex A. Financial Bid Response Form